ABUS
ABUS
Positions held
Your positionsABUS isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · Arbutus Announces Final Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
2026-09-30 · Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer
2026-08-25 · Health Care Roundup: Market Talk
2026-08-24 · Arbutus Biopharma Launches $230 Million Tender Offer for Common Shares
2026-08-21 · Sector Update: Healthcare Stocks Advance Late Afternoon
2026-08-21 · Sector Update: Healthcare Stocks Advance in Afternoon Trading
2026-08-21 · Arbutus Biopharma shares jump after unveiling $230 million share buyback plan
2026-08-21 · Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday
2026-08-21 · Sector Update: Healthcare
2026-08-21 · ABUS Stock Surges 10% Today — What’s Driving This Super Rally?
2026-08-21 · Arbutus Biopharma Plans Up to $230 Million Modified Dutch Auction Tender Offer
Price (daily)
Full chart · RSI · MACD · patterns